A recent study in Nature Materials introduces an inhalable nanozyme treatment for viral pneumonia, showing promising results ...

A common heart drug may slow the progression of Huntington's disease (HD), according to a new study by University of Iowa Health Care researchers.

Microscopes traditionally resolve only the thin layer of cellular activity within a narrow focal plane. Now scientists have ...

PEG-MGF, or polyethylene glycol-modified mechanogrowth factor, is a peptide that has garnered attention in scientific ...

Two-dimensional materials such as graphene are not only ultrathin, but also extremely sensitive. Researchers have therefore been trying for years to develop highly sensitive biosensors that utilize ...

YETI Holdings, with its recent earnings beat, presents a value opportunity for double-digit returns, despite geopolitical ...

Researchers developed a method to functionalize graphene using a 1-nm dielectric carbon layer, enabling capture molecules to ...

Remix Therapeutics (Remix), a clinical-stage biotechnology company developing small molecule therapies to modulate RNA ...

PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...

WNKs sense osmotic pressure by binding specific water molecules to the inactive dimeric configuration of WNK1 and WNK3, integrating signals with chloride inhibition as demonstrated by mutagenesis and ...

In a brilliant example of cross-discipline and cross-faculty working, researchers from Queen Mary University of London’s ...

Injectable hydrogel uses dual mechanisms for customizable drug release, achieving burst, linear, or delayed patterns over two weeks, with potential to reduce injection frequency.